PD-L1 inhibitor-induced worsening of eosinophilic obstructive lung disease successfully rescued with anti-interleukin 5 receptor (IL-5R) therapy

Affiliations

• ¹ Department of Respiratory Diseases, University of Montpellier, CHU Montpellier, Montpellier, France.
• ² Department of Respiratory Diseases, University of Montpellier, CHU Montpellier, Montpellier, France; Department of Medical Information, University of Montpellier, CHU Montpellier, Montpellier, France.
• ³ Department of Respiratory Diseases, University of Montpellier, CHU Montpellier, Montpellier, France; PhyMedExp, University of Montpellier, CNRS, INSERM, CHU Montpellier, Montpellier, France.
• ⁴ Department of Respiratory Diseases, University of Montpellier, CHU Montpellier, Montpellier, France; PhyMedExp, University of Montpellier, CNRS, INSERM, CHU Montpellier, Montpellier, France. Electronic address: j-charriot@chu-montpellier.fr.